Considering the fact that ER is expressed in most of the surgical prolactinoma specimens examined and that, as described above, estrogen facilitates lactotroph tumor cell growth, the addition of an ER antagonist to conventional dopamine receptor agonist is reasonable and awaits further study. The gene discussed is ESR1; the disease is neoplasm.